You are here

Research & Evidence

This pilot study underscores the importance of partnerships among businesses, public health advocacy organizations, and political leaders whose shared goal is to improve the health and wellbeing of Americans and enhance the global competitiveness of domestic enterprises.
Results From the Bipartisan Policy Center's CEO Council Physical Activity Challenge to American Business
Berko, Jeff MPH; Goetzel, Ron Z. PhD; Roemer, Enid Chung PhD; Kent, Karen MPH; Marchibroda, Janet MBA
Journal of Occupational & Environmental Medicine

2000

Arnold Barnett, PhD; Howard Birnbaum, PhD; Pierre-Yves Cremieux, PhD; A. Mark Fendrick, MD; and Mitchell Slavin, PharmD. "The Costs of Cancer to a Major Employer in the United States: A Case-Control Analysis." The American Journal of Managed Care, November 2000.

Reliable data on the costs and outcomes of different healthcare interventions are essential for efficient distribution of healthcare resources and evaluation of quality of healthcare.The National Institutes of Health estimates total annual costs for cancer in the United States at $107 billion annually. These cancer costs represented roughly 5% of all healthcare expenditures in 1995. These high healthcare costs translate into significantexpenses for US employers. As cancer treatment improves and the number of patients in remission or recovery increases, the management of cancer care is becoming increasingly important. This trend has led managed care organizations to focus on assessing the likely costs of cancer care and outcomes for different types of cancer.

Pages